Transient global ischemia in rats induces delayed death of hippocampal CA1 neurons. Early events include caspase activation, cleavage of anti-death Bcl-2 family proteins and large mitochondrial channel activity. However, whether these events have a causal role in ischemia-induced neuronal death is unclear. We found that the Bcl-2 and Bcl-x L inhibitor ABT-737, which enhances death of tumor cells, protected rats against neuronal death in a clinically relevant model of brain ischemia. Bcl-x L is prominently expressed in adult neurons and can be cleaved by caspases to generate a pro-death fragment, DN-Bcl-x L . We found that ABT-737 administered before or after ischemia inhibited DN-Bcl-x L -induced mitochondrial channel activity and neuronal death. To establish a causal role for DN-Bcl-x L , we generated knock-in mice expressing a caspase-resistant form of Bcl-x L . The knock-in mice exhibited markedly reduced mitochondrial channel activity and reduced vulnerability to ischemia-induced neuronal death. These findings suggest that truncated Bcl-x L could be a potentially important therapeutic target in ischemic brain injury.
a r t I C l e S Transient global or forebrain ischemia, arising as a consequence of cardiac arrest or cardiac surgery in humans or induced experimentally in animals, causes selective, delayed death of hippocampal CA1 pyramidal neurons and cognitive deficits at 3-7 d after insult [1] [2] [3] . Early events include the disruption of the functional integrity of the outer mitochondrial membrane by the formation of large ion channels, mitochondrial release of cytochrome c and activation of caspases [4] [5] [6] .
Although it is clear that caspases are engaged in response to global ischemia, the role of caspase substrates in global ischemia-induced death is not fully understood 7 .
Bcl-2 family proteins regulate apoptotic cell death by controlling the permeability of the outer mitochondrial membrane. The prevailing view is that anti-apoptotic Bcl-2 family members such as Bcl-x L prevent homo-oligomerization of pro-apoptotic family members Bax and Bak in the outer mitochondrial membrane, thereby preventing the release of cytochrome c to promote caspase activation and apoptotic cell death. Bcl-2 and Bcl-x L act by directly inhibiting Bax and Bak and by inhibiting the activators of Bax and Bak 8, 9 . The cancer chemotherapeutic agent ABT-737 mimics the BH3 domain of proapoptotic family proteins and binds Bcl-x L , Bcl-2 and Bcl-w with high affinity to inhibit their anti-apoptotic activity [10] [11] [12] [13] .
Bcl-x L not only influences neuronal survival, but also modulates neuronal activity. Under physiological conditions, introduction of recombinant Bcl-x L protein into the presynaptic terminal of the squid giant axon potentiates transmitter release and vesicle recycling following intense synaptic activity 14 , and injection of the Bcl-x L inhibitor ABT-737 slows recovery of synaptic responses. In contrast, under hypoxic conditions, ABT-737 increases synaptic transmission, preventing hypoxia-induced synaptic rundown at the squid giant synapse 15 . Moreover, caspase activation is critical to the induction of long term depression at Schaffer collateral-to-CA1 synapses 16 . This raises the unexpected possibility that Bcl-x L and/or other targets of ABT-737 can have opposing effects on synaptic strength, depending on whether the synapse is hypoxic. One way in which this could occur is through proteolytic cleavage of Bcl-x L to generate its pro-death fragment, ∆N-Bcl-x L 17 . Bcl-2 family proteins are substrates for caspases and other proteases; cleavage generally elicits pro-death activitiy [18] [19] [20] . Application of recombinant ∆N-Bcl-x L , the C-terminal cleavage product of Bcl-x L , activates large conductance channel activity 21 that mimics channel activity in mitochondria of post-ischemic neurons 6, 21 . We examined the role of caspase-cleaved Bcl-x L in the formation of mitochondrial channel activity. We found that treatment of animals with ABT-737 before or after induction of global ischemia in vivo markedly inhibited ischemia-induced formation of large channel activity in mitochondria and neuronal death. Mutation of the caspase cleavage sites in Bcl-x L in mice attenuated ischemia-induced neuronal death. Our findings indicate that ABT-737 prevents cleavage of Bcl-x L and inhibits the activity of cleaved Bcl-x L , thereby affording protection against ischemia-induced neuronal death. a r t I C l e S RESULTS ABT-737 attenuates ischemia-induced neuronal death in rats Transient global ischemia in rats, induced by the four-vessel occlusion model (10 min), followed by reperfusion, mimics global ischemia arising in human brain following cardiac arrest 5, 6, 22 . Although the entire brain becomes hypoxic, neurons throughout the brain depolarize, ATP is depleted and a massive rise in intracellular Ca 2+ occurs, global ischemia elicits highly selective, delayed death of primarily hippocampal CA1 pyramidal neurons. We first sought to determine whether anti-apoptotic Bcl-x L , which is abundantly expressed in adult hippocampal neurons 23 , protects neurons from ischemia-induced death. Pretreatment of rats with ABT-737 (1 µM final, a concentration sufficient to inhibit Bcl-x L in vivo 10 , injected unilaterally into the right ventricle stereotactically at 1 h before transient global ischemia) substantially inhibited neuronal death in the hippocampal CA1, as assessed by the number of neurons that were stained with Fluoro-Jade, a marker of degenerating neurons ( Fig. 1a,b) , and by neuronal counts of toluidine blue-stained sections at 6 d post-ischemia relative to vehicle-injected rats subjected to ischemia ( Supplementary Fig. 1a,b) .
To test ABT-737 in a more clinically relevant scenario, we administered ABT-737 at 15 min or 1 h following reperfusion. Under these conditions, ABT-737 afforded robust neuroprotection against ischemia-induced neuronal death in the hippocampal CA1 ( Fig. 1a,b ). In addition, ABT-737 attenuated activated caspase-3 as late as 5 d after ischemia ( Supplementary Fig. 2) . This is an unexpected finding given the extensive evidence that caspase-3 activity is increased as early as 1-3 h after ischemia 5, 21, 24, 25 and peaks at approximately 24 h after ischemia 5,24 ; in addition, ultrastructural studies 26 provide compelling evidence that post-ischemic neurons exhibit morphological features of necrotic injury. These findings, together with our previous results, indicate that ABT-737 suppresses a pro-death activity over an extensive time period.
ABT-737 inhibits ischemia-induced mitochondrial channel activity Transient global ischemia in vivo induces large-channel openings in the outer membrane of mitochondria in brain 6, 21 . To examine the effect of ABT-737 administered in vivo on ischemia-induced largechannel activity in mitochondria in vivo, we isolated whole mitochondria from the hippocampal CA1 at 1 h after ischemia or sham surgery and performed patch-clamp recording. ABT-737 (administered at 1 h before ischemia) had little or no effect on sham-operated rats, but markedly attenuated the appearance of ischemia-induced large (>760 pS) and intermediate (180-760 pS) conductance mitochondrial channel activity and increased the closed time and prevalence of small (<180 pS) channel activity ( Fig. 2a-d) . ABT-737 reduced the peak conductance of channel openings assessed by current-voltage analysis ( Fig. 2e) and peak conductance at a single voltage (ABT-737-treated mitochondria, 118 ± 24 pS, n = 5 mitochondria, 3 animals; vehicletreated mitochondria, 922 ± 76 pS, n = 7 mitochondria, 3 animals, P < 0.0001). Thus, ABT-737 attenuates ischemia-induced induction of mitochondrial channel activity.
To examine the direct effect of ABT-737 mitochondrial channel activity in vitro, we isolated mitochondria from hippocampal CA1 at 1 h npg a r t I C l e S after insult and recorded channel activity in the absence and presence of ABT-737 via the patch pipette and bath perfusate. ABT-737 markedly reduced ischemia-induced channel activity in isolated postischemic mitochondria (Fig. 3a,b) . Moreover, ABT-737 reduced the peak conductance of channel openings, as assessed by current-voltage analysis ( Fig. 3c ) and by determination of channel openings at a single voltage (ABT-737, 398 ± 62 pS, n = 8; vehicle, 966 ± 241 pS, n = 11; P < 0.05).
Because ABT-737 does not inhibit the pro-apoptotic Bcl-2 family members Bax and Bak 10 , these proteins are presumably not the targets of ABT-737 that mediate its protection against ischemic injury. However, Bcl-x L , a known target of ABT-737 (ref. 10), can be proteolytically processed to release pro-apoptotic C-terminal cleavage fragments 17, 27 . We examined the effect of ischemia on the appearance of cleaved Bcl-x L in CA1. Under physiological conditions, ∆N61-Bcl-x L was present at low abundance ( Fig. 4) , consistent with the possibility that caspases may have physiological, as well as pathological, functions 16 . Ischemia increased ∆N61-Bcl-x L abundance, as determined by Western blots probed with an antibody specific for ∆N61-Bcl-x L (n = 5 independent experiments). Ischemia promoted the formation of cleaved Bcl-x L , evident at 1 h and at 24 h, but levels declined to near control values by 48 h, the time at which histologically detectable cell death is first apparent ( Fig. 4 and Supplementary Fig. 3 ) 21 . In contrast, full-length Bcl-2 and Bcl-w were increased ( Supplementary Fig. 3) , with little or no evidence of cleavage fragments (data not shown).
ABT-737 inhibits DN-Bcl-x L -elicited channel activity
In squid giant synapse, injection of ABT-737 into the presynaptic terminal slows the recovery of synaptic responses after repetitive synaptic activity, but ameliorates hypoxia-induced synaptic rundown 15 , raising the unexpected possibility that Bcl-x L and/or other targets of ABT-737 can produce opposing effects on synaptic strength. In response to injurious stimuli, endogenous Bcl-x L can be cleaved into two fragments, ∆N61-Bcl-x L and ∆N76-Bcl-x L , each of which elicits cell death in cultured cells 17, 27 . We tested the effects of recombinant ∆N61-Bcl-x L and ∆N76-Bcl-x L , introduced via the patch pipette, on the induction of channel activity under control (non-ischemic) conditions. Both proteins induced discrete intermediate-and large-conductance channel openings in response to a wide range of amplitudes ( Fig. 5a,b and Supplementary Fig. 4a,b) 15, 21 . Although application of ABT-737 alone decreased the appearance of small-conductance channel activity ( Fig. 5a-c) , application of ABT-737 and recombinant cleaved Bcl-x L via the patch pipette prevented the appearance of large-and intermediate-conductance channel activity (Fig. 5a-c and Supplementary  Fig. 4a,b ) and decreased the ∆N61-Bcl-x L -elicited peak conductance (∆N61-Bcl-x L , 911 ± 81 pS; ∆N61-Bcl-x L + ABT-737, 384 ± 58 pS; n = 25 of each, P < 0.01). Application of ABT-737 to mitochondria produced a greater inhibition of ∆N61-Bcl-x L -elicited than ∆N76-Bcl-x Lelicited channel activity (Fig. 5a-c and Supplementary Fig. 4a,b) .
Although ∆N61-Bcl-x L and ∆N76-Bcl-x L elicited channel activity similar to that reported for the pro-apoptotic Bcl-2 family protein Bax 21,28,29 , ABT-737 does not bind or inhibit Bax 30 . Thus, Bax is not a likely candidate for the ischemia-induced large-conductance channel activity. For subsequent experiments, we focused on ∆N61-Bcl-x L (hereafter referred to as ∆N-Bcl-x L ).
Caspase cleavage of Bcl-2 and Bcl-x L has been reported to promote the release of cytochrome c from lipid vesicles and from mitochondria 31, 32 . Although recombinant ∆N-Bcl-x L promoted only limited release of cytochrome c from hippocampal mitochondria, this effect was reversed by 1 µM ABT-737 ( Fig. 5d-i and Supplementary Fig. 5 ), suggesting that ABT-737 can inhibit the direct effects of ∆N-Bcl-x L .
DN-Bcl-x L induces Bax-and Bak-independent neuronal death ∆N-Bcl-x L may act directly to promote neuronal death or may act as an activator of Bax or Bak to promote death. To examine whether ∆N-Bclx L elicits cell death in neurons in a Bax-or Bak-independent manner, we transfected Bax/Bak double knockout mouse embryonic fibroblasts (MEFs) with a plasmid expressing N-Bcl-x L . Transfected cells were marked with co-transfected eGFP and viability was assessed by MTS assay (see Online Methods) 18 h after transfection. Under these conditions, N-Bcl-x L induced cell death in cells lacking Bax and Bak, whereas eGFP alone did not. Application of ABT-737 to cells at the time of transfection markedly inhibited ∆N-Bcl-x L -elicited cell death (Fig. 6a) . These findings indicate that N-Bcl-x L is sufficient to trigger cell death, even in the absence of Bax and Bak. In contrast, experiments performed on single knockout MEFs lacking either Bax or Bak revealed that Bax Full-length blots are presented in Supplementary Figure 11 .
a r t I C l e S and Bak participated in N-Bcl-x L -induced cell death and that ABT-737 was ineffective at inhibiting this death (Supplementary Fig. 6 ), presumably as a result of the effects of Bax and/or Bak alone.
To verify that expression of N-Bcl-x L can trigger neuronal death, we coexpressed N-Bcl-x L and eGFP in primary hippocampal neurons (18 d in vitro; Fig. 6b ). At 1-2 d after transfection, neurons expressing eGFP alone exhibited little or no cell death. In contrast, neurons expressing N-Bcl-x L exhibited substantial cell death, relative to the eGFP control cells, as assessed by caspase-3-like activity (∆N-Bcl-x L + eGFP, 44 ± 2%, n = 30 cells; eGFP alone, 8 ± 2%, n = 16 from three independent experiments; P < 0.05). In a separate experiment, ABT-737 markedly attenuated the death of neurons expressing N-Bcl-x L , as assessed by cell morphology (see Online Methods) and propidium iodide uptake (a marker of degenerating neurons and cells) by eGFP-positive neurons (Fig. 6c) . In contrast, neurons expressing eGFP alone exhibited little or no cell death. Neurons expressing Bax exhibited less cell death than neurons expressing N-Bcl-x L , and the small fraction of cells exhibiting Baxelicited cell death were not protected by ABT-737.
Cleavage-resistant Bcl-x L mice resist
To determine whether protease cleavage of endogenous Bcl-x L contributes to cell death in CA1 neurons following ischemia-reperfusion, we generated knock-in mice in which Bcl-x L harbors mutations at both caspase cleavage sites, D61A and D76A, rendering Bcl-x L resistant to cleavage by caspases ( Fig. 7 and Supplementary Fig. 7) . The mice were viable and fertile and exhibited no gross morphological changes in brain anatomy. We subjected wild-type and homozygous Bcl-x L cleavage-resistant mice to either sham surgery or transient global ischemia induced by bilateral common artery occlusion, followed by reperfusion (see Online Methods). Sham-operated (control) wild-type and knock-in mice did not differ in the number of neurons in the hippocampal CA1 ( Fig. 7a,b ) and showed no signs of degeneration, as assessed by Fluoro-Jade staining ( Supplementary  Fig. 8) . In wild-type mice subjected to global ischemia, we observed substantial cell death in the CA1, as assessed by neuronal counts of the hippocampal CA1 in toluidine blue-stained sections 6 d after surgery relative to sham wild-type controls. In contrast with wildtype mice, cleavage-resistant Bcl-x L knock-in mice were resistant to npg a r t I C l e S ischemia-induced neuronal death in the hippocampal CA1 (Fig. 7a,b) and exhibited markedly less ∆N-Bcl-x L in the hippocampus (Fig. 7c) . Furthermore, knock-in mice were rescued from ischemia-induced neuronal degeneration, as assessed by Fluoro-Jade staining at 5 d after ischemia (Supplementary Fig. 8 ).
To determine whether blocking cleavage of Bcl-x L attenuates mitochondrial channel activity, we isolated mitochondria from sham and post-ischemic knock-in mice and wild-type littermates and performed patch-clamp recordings of whole mitochondria. Non-ischemic wild-type and knock-in mice failed to show substantial differences in large-and intermediate-conductance channel activity. In contrast, although ischemia elicited an increase in channel activity in wild-type mitochondria compared with nonischemic wild-type controls, and mitochondria isolated from ischemic knock-in animals had substantially less channel activity than that of ischemic wild-type mice (Fig. 7d,e ), suggesting that cleavage of endogenous Bcl-x L is required for the increase in mitochondrial channel activity after ischemia in mouse brain.
To examine the effect of cleavage-resistant Bcl-x L in a second model of neuronal death, we prepared hippocampal slice cultures from homozygous knock-in mice, heterozygous and wild-type littermates, and from wild-type rats (9 d in vitro) and subjected slices to oxygen-glucose deprivation (OGD), a well-established in vitro model of global ischemia (45 min, followed by 2 d of reperfusion). Hippocampal slices from knock-in mice exhibited a marked reduction in OGD-induced neuronal death compared with slices from heterozyous or wild-type littermates, as assessed by propidium iodide uptake (Supplementary Fig. 9a,b) . OGD-induced formation of ∆N-Bcl-x L in hippocampal slices from wild-type mice was increased compared with knock-in cleavage-resistant Bcl-x L mice (Fig. 7c) . To examine the effect of ABT-737, we carried out OGD in rat hippocampal slices. OGD induced cleavage of Bcl-x L to generate ∆N-Bcl-x L and elicited neuronal death (Supplementary Fig. 10a,b) . Application of ABT-737 (5 µM) to rat hippocampal slices attenuated OGD-induced neuronal death, as assessed by propidium iodide uptake at 24-48 h after ischemia (Supplementary Fig. 10b ). Taken together, these data strongly suggest that cleavage of Bcl-x L contributes to the selective delayed neurodegeneration associated with global ischemia and that truncated Bcl-x L contributes to delayed ischemia-induced death of hippocampal neurons.
DISCUSSION
Transient global or forebrain ischemia arising as a consequence of cardiac arrest or open heart surgery elicits selective, delayed death of hippocampal CA1 neurons and cognitive deficits [1] [2] [3] 33, 34 . The appearance of large-channel activity in mitochondrial membranes and release of cytochrome c are hallmarks of the early post-ischemic period. Proteolytic cleavage of the anti-apoptotic protein Bcl-x L to ∆N-Bcl-x L is associated with the formation of large-conductance mitochondrial channels and with the release of cytochrome c in post-ischemic neurons 6, 21 . We found that expression of ∆N-Bcl-x L in hippocampal neurons and MEFs lacking Bax and Bak elicited cell death. Treatment of animals with the Bcl-2 and Bcl-x L inhibitor ABT-737, which elicits apoptosis in a wide array of tumor cells [10] [11] [12] [13] , before or after ischemia, markedly attenuated ischemia-induced cleavage of Bcl-x L and formation of large-channel activity in the mitochondrial outer membrane, and afforded robust protection of CA1 neurons. Consistent with this, ischemia-induced mitochondrial channel activity and death of hippocampal neurons was attenuated in vivo and in organotypically cultured hippocampal slices from knock-in mice expressing a mutated form of Bcl-x L that is resistant to protease-dependent cleavage. These findings support a role for ∆N-Bcl-x L in the delayed cell death of hippocampal CA1 neurons and implicate ∆N-Bcl-x L as a putative target for therapeutic intervention in brain ischemic injury. It remains to be seen whether ABT-737 administered many hours after a r t I C l e S the ischemic event would still afford protection. ABT-737 is the most specific and selective small molecule inhibitor of Bcl-x L and therefore provides important proof-of-principle for the development of future therapeutic compounds. Other agents similar to ABT-737 have been designed that may cross the blood-brain barrier, but their specificity and selectivity have not withstood the rigorous tests that have been applied to ABT-737. Nevertheless, these other drugs may have clinical relevance in brain ischemia models in future studies.
ABT-737 protects hippocampal neurons from ischemic injury Treatment of animals with ABT-737 before or after induction of global ischemia afforded robust protection of hippocampal CA1 neurons in a clinically relevant model of global ischemia. These findings are somewhat unexpected in that ABT-737 is a BH3 mimetic, which inhibits antiapoptotic Bcl-2 family members by binding in the hydrophobic cleft that is typically occupied by pro-apoptotic BH3 domain-only proteins such as Bim and Bad 10 . ABT-737 exhibits high affinity for Bcl-x L , Bcl-2 and Bcl-w, with approximately tenfold higher affinity for Bcl-x L than for Bcl-2 (ref. 10). ABT-737 promotes apoptosis in lymphoma, multiple myeloma and small-cell lung carcinoma lines, as well as in primary patient-derived cancer cells, thereby effectively suppressing tumors [10] [11] [12] [13] . ABT-737 (ABT-263) is presently undergoing clinical trials as an antitumorigenic agent that promotes regression of solid tumors [10] [11] [12] [13] . In tumor cells, the mechanism by which ABT-737 elicits cell death is well delineated: ABT-737 sequesters Bcl-x L away from pro-apoptotic BH3only proteins. When unleashed, these proteins initiate the oligomerization of Bax and Bak, which permeabilize the outer mitochondrial membrane 8, 9 . Nevertheless, given that ABT-737 can bind both antiapoptotic full-length Bcl-x L and pro-apoptotic ∆N-Bcl-x L , it would be difficult to infer from findings in squid or rats what the actual effect of ABT-737 would be in humans in a clinical context. Our findings are consistent with a model in which ABT-737 also binds both anti-apoptotic and pro-apoptotic ∆N-Bcl-x L , thereby aborting ischemia-induced neuronal death by preventing cleavage of full-length Bcl-x L (as in Fig. 4a,b) and by blocking the channel activity and death-inducing effects of cleaved Bcl-x L . Consistent with this, expression of ∆N-Bcl-x L , but not Bax, elicited cell death in hippocampal neurons, and ∆N-Bcl-x L also produced death in MEFs lacking Bax and Bak. Although ABT-737 attenuated ∆N-Bcl-x L -elicited cell death in hippocampal neurons and Bax −/− ; Bak −/− double knockout MEFs (Fig. 6a) , ABT-737 had little or no effect on cell death in single knockout MEFs that contain Bax or Bak. Thus, Bax and Bak may also contribute to cell death observed in MEFs. In adult neurons, however, endogenous Bcl-x L abundance is still high at ages at which Bax and Bak expression have declined 23 , and, although genetic ablation of Bax protects against cardiac ischemia 35 and Bax inhibitors protect against brain ischemia in other models 29 , Bax inhibitors do not protect adult mice from ischemic injury induced by middle cerebral artery occlusion 36 , and endogenous and overexpressed Bax and Bak can be protective in the brain depending on the developmental stage, death stimulus and brain subregion 37, 38 . Furthermore, we found that exogenously expressed Bax did not increase death of cultured hippocampal neurons (see Fig. 6c ), indicating that these neurons are not very sensitive to Bax. Nevertheless, cleaved Bcl-x L may stimulate both Bax-and Bak-dependent and independent death.
Bcl-x L can be cleaved by both calpain and caspases 17, 39 . Unlike calpain, which has less defined substrate cleavage sites, caspases cleave specifically after aspartic acid residues, and we found that mutation of the two known caspase cleavage sites at Asp61 and Asp76 of endogenous Bcl-x L protected neurons from ischemic injury. The specific caspases required to generate the pro-death ∆N-Bcl-x L fragment in neurons subjected to global ischemia in vivo or to OGD in organotypically cultured hippocampal slices are not known. The responsible caspases could be activated by a pathway before mitochondrial involvement or by mechanisms that do not involve mitochondrial permeabilization. These possibilities are consistent with the nonconsensus caspase cleavage recognition sites in Bcl-x L . Caspasecleaved Bcl-x L could also potentially lead to increased cleavage of full-length Bcl-x L if ∆N-Bcl-x L leads to mitochondrial permeabilization and subsequent amplification of caspase activity. Regardless of the specific caspases involved, these findings are consistent with previous observations that caspase inhibitors ameliorate global ischemia-induced neuronal death 24, 40, 41 .
ABT-737 inhibits DN-Bcl-x L induced channel activity
We found that ABT-737 can inhibit functional activity associated with truncated, pro-apoptotic forms of Bcl-x L , leading to the protection of post-ischemic neurons. First, ABT-737 inhibited the large-channel activity in the outer mitochondrial membrane elicited by recombinant ∆N61-Bcl-x L and ∆N76-Bcl-x L applied via the patch pipette. Second, ABT-737 attenuated ∆N-Bcl-x L -elicited cell death in hippocampal neurons and MEFs lacking Bax and Bak. These findings provide a mechanism by which ABT-737 affords neuroprotection: namely, ABT-737 directly binds and inhibits ∆N-Bcl-x L and thereby prevents its ability to permeabilize the outer mitochondrial membrane and promote death in hippocampal neurons. Although these results address inhibition of ∆N-Bcl-x L function by ABT-737, they do not establish exactly how ABT-737 inhibits channel activity. We envision at least three possible mechanisms by which ABT-737 might function. First, ABT-737 could act directly on ∆N-Bcl-x L . This is supported by the finding that ABT-737 can inhibit the effects of recombinant, as well as overexpressed, ∆N-Bcl-x L . Second, ABT-737 might act directly on full-length Bcl-x L to render it less sensitive to proteolytic digestion, thereby blocking the cleavage of Bcl-x L to ∆N-Bcl-x L . Third, ABT-737 could act indirectly to reduce caspase cleavage of full-length Bcl-x L to ∆N-Bcl-x L in a feedforward loop by suppressing the ability of ∆N-Bcl-x L to stimulate mitochondrial permeabilization, leading to amplification of caspase activity. The latter two possibilities are consistent with our immunoblot analysis of processed Bcl-x L in ischemic brain.
We identified a specific role for the cleavage of Bcl-x L in ischemiainduced neuronal death and our results provide evidence for a ∆N-Bcl-x Ldependent activation of a Bax-like apoptotic pathway. However, these observations do not necessarily implicate apoptotic cell death as defined morphologically. Although global ischemia-induced neuronal death in the hippocampal CA1 has been attributed to apoptosis defined as caspase-dependent death 42 , analysis of the hippocampal CA1 by electron microscopy following global ischemic injury, and in other ischemia models, reveals necrotic morphology 26, 43 . In addition, we recently found that Bcl-x L increases mitochondrial energetic efficiency 44, 45 . Thus, loss of full-length Bcl-x L , together with ∆N-Bcl-x Linduced mitochondrial damage, could result in a plethora of cellular defects leading to a range of cellular morphologies.
In summary, our results support the theory that ischemic insult triggers cleavage of full length Bcl-x L to generate its pro-apoptotic cleavage product, ∆N-Bcl-x L , as ∆N-Bcl-x L expressed in hippocampal neurons and in MEFs lacking Bax and Bak elicited cell death. We found that ∆N-Bcl-x L is critical to neuronal death in a clinically relevant model of global ischemia. A key event is the disruption of the functional integrity of the outer mitochondrial membrane, as evident by the increase in large-channel activity in the early post-ischemic period. In addition, we found that ABT-737, which is known to promote apoptosis and death of tumorigenic cells, affords robust npg a r t I C l e S protection of hippocampal neurons from global ischemia-induced neuronal death. Together, these findings identify Bcl-x L as a putative therapeutic target for intervention in the neuronal injury and cognitive deficits associated with global ischemia.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
